Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, January 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 270 articles:
HTML format


 

Single Articles

  1. YOKOI E, Mabuchi S, Takahashi R, Matsumoto Y, et al
    Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    J Gynecol Oncol. 2016 Dec 8:e19. doi: 10.3802/jgo.2017.
    Abstract    

    Abstract available

  2. LI C, Ge X, Wang L
    Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Biomed Pharmacother. 2016;86:628-636.
    Abstract    

    Abstract available

  3. HENRIQUE LQ, Campaner AB, d'Avila FS
    Cervical Cancer Screening of Adolescents Should Not Be Encouraged.
    J Low Genit Tract Dis. 2017;21:21-25.
    Abstract    

    Abstract available

  4. SHARMA A, Jyoti K, Bansal V, Jain UK, et al
    Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
    Mater Sci Eng C Mater Biol Appl. 2017;72:69-76.
    Abstract    

    Abstract available

  5. SHARMA M, Seoud M, Kim JJ
    Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31222.
    Abstract    

    Abstract available

  6. LUVERO D, Plotti F, Angioli R
    Reply: "Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-years follow-up".
    Med Oncol. 2017;34:14.
    Abstract    



  7. ARUMUGAM S, Bandil K, Proksch P, Murugiyan K, et al
    Effects of A.marina-Derived Isoquercitrin on TNF-Related Apoptosis-Inducing Ligand Receptor (TRAIL-R) Expression and Apoptosis Induction in Cervical Cancer Cells.
    Appl Biochem Biotechnol. 2016 Dec 24. doi: 10.1007/s12010-016-2355.
    Abstract    

    Abstract available

  8. ZHANG H, Zhang S
    The expression of Foxp3 and TLR4 in cervical cancer: association with immune escape and clinical pathology.
    Arch Gynecol Obstet. 2016 Dec 24. doi: 10.1007/s00404-016-4277.
    Abstract    

    Abstract available

  9. RIZOU N, Moris D, Pikoulis E, Dimitrokallis N, et al
    Minimally Invasive Lymphadenectomy in Uterine Cervical Cancer: A Systematic Review.
    Anticancer Res. 2017;37:335-342.
    Abstract    

    Abstract available

  10. CHO O, Noh OK, Oh YT, Chang SJ, et al
    Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer.
    Anticancer Res. 2017;37:327-334.
    Abstract    

    Abstract available

  11. MURAKAMI T, Murata T, Kawaguchi K, Kiyuna T, et al
    Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
    Anticancer Res. 2017;37:61-65.
    Abstract    

    Abstract available

  12. LI H, Lu Y, Pang Y, Li M, et al
    Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
    Biomed Pharmacother. 2016;86:324-333.
    Abstract    

    Abstract available

  13. DIVER E, Hinchcliff E, Gockley A, Melamed A, et al
    Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated with Reduced Morbidity and Similar Survival Outcomes Compared with Laparotomy.
    J Minim Invasive Gynecol. 2016 Dec 20. pii: S1553-4650(16)31213.
    Abstract    

    Abstract available

  14. JU FJ
    Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient.
    Onco Targets Ther. 2016;9:7555-7561.
    Abstract    

    Abstract available

  15. HAELENS A, Roche L, Bastos J, Woronoff AS, et al
    Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study.
    Eur J Cancer Prev. 2017;26 Trends in cancer net survival in six European.
    Abstract    

    Abstract available

  16. CONSTANTINOU P, Sicsic J, Franc C
    Effect of pay-for-performance on cervical cancer screening participation in France.
    Int J Health Econ Manag. 2016 Dec 22. doi: 10.1007/s10754-016-9207.
    Abstract    

    Abstract available

  17. RUPANI MP, Pawar AB, Bansal RK, Dalal M, et al
    Cross-sectional study to assess the need to commence opportunistic screening of women for cervical cancer presenting with sexually transmitted disease in Western India.
    Eur J Cancer Care (Engl). 2016 Dec 22. doi: 10.1111/ecc.12626.
    Abstract    

    Abstract available

  18. GHIB PARA CG, Sferdian MF, Dascau V, Paiusan L, et al
    Clinical and morphological considerations in one case with cervical cancer and right ureterohydronephrosis.
    Rom J Morphol Embryol. 2016;57:1155-1158.
    Abstract    

    Abstract available

  19. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    Abstract    

    Abstract available

  20. CHOI Y, Ahn KJ, Park SK, Cho H, et al
    Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy.
    Radiat Oncol J. 2016 Dec 22. doi: 10.3857/roj.2016.01977.
    Abstract    

    Abstract available

  21. WU Q, Wang Y, Shi L, Dong L, et al
    Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging of Cervical Cancer With Different b-Values.
    J Comput Assist Tomogr. 2016 Dec 15. doi: 10.1097/RCT.0000000000000569.
    Abstract    

    Abstract available

  22. YOSHIMOTO M, Tokuda A, Nishiwaki K, Sengoku K, et al
    The Protein Interacting with Carboxyl Terminus-1 codon 389 polymorphism impairs protein interacting with carboxyl terminus-1 function and is a risk factor for uterine cervical cancer.
    Mol Carcinog. 2016 Dec 20. doi: 10.1002/mc.22608.
    Abstract    

    Abstract available

  23. ICHIYASU H, Sakamoto Y, Yoshida C, Sakamoto K, et al
    Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy
    Respir Med Case Rep. 2016;20:51-54.
    Abstract    

    Abstract available

  24. LI XL, Du DF, Jiang H
    The learning curves of robotic and three-dimensional laparoscopic surgery in cervical cancer.
    J Cancer. 2016;7:2304-2308.
    Abstract    

    Abstract available

  25. ABBOUD S, De Penning E, Brawner BM, Menon U, et al
    Cervical Cancer Screening Among Arab Women in the United States: An Integrative Review.
    Oncol Nurs Forum. 2017;44:E20-E33.
    Abstract    

    Abstract available

  26. OHNO T, Noda SE, Okonogi N, Murata K, et al
    In-room computed tomography-based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study.
    J Radiat Res. 2016.
    Abstract    

    Abstract available

  27. SHOLAPURKAR SL
    Re: Adverse psychological outcomes following colposcopy and related procedures: a systematic review: Psychological sequelae of cervical cytology screening: the need for continual awareness and pre-emptive steps.
    BJOG. 2016;123:2224.
    Abstract    



  28. PENG C, Liu LZ, Zheng W, Xie YJ, et al
    Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy?
    Eur J Radiol. 2016;85:2111-2118.
    Abstract    

    Abstract available

  29. CHRYSAGI A, Kaparos G, Vrekoussis T, Yiannou P, et al
    Prevalence of HPV genotypes in cervical adenocarcinoma: a study in Greek women.
    J BUON. 2016;21:666-72.
    Abstract    

    Abstract available

  30. PAUNOVIC V, Konevic S, Paunovic T
    Association of human papillomavirus infection with cytology, colposcopy, histopathology, and risk factors in the development of low and high-grade lesions of the cervix.
    J BUON. 2016;21:659-65.
    Abstract    

    Abstract available

  31. MEHDORN M, Petersen TO, Bartels M, Jansen-Winkeln B, et al
    Psoas abscess secondary to retroperitoneal distant metastases from squamous cell carcinoma of the cervix with thrombosis of the inferior vena cava and duodenal infiltration treated by Whipple procedure: A case report and review of the literature.
    BMC Surg. 2016;16:55.
    Abstract    

    Abstract available

  32. WELTERS MJ, van der Sluis TC, van Meir H, Loof NM, et al
    Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.
    Sci Transl Med. 2016;8:334ra52.
    Abstract    

    Abstract available

  33. AICH RK, Mondal NK, Chhatui B, Sepai HM, et al
    Relevance of risk factors of breast cancer in women: An Eastern Indian scenario.
    J Cancer Res Ther. 2016;12:302-8.
    Abstract    

    Abstract available

  34. SHARMA M, Revannasiddaiah S, Gupta M, Seam RK, et al
    Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: Results of a prospective randomized phase III trial.
    J Cancer Res Ther. 2016;12:103-8.
    Abstract    

    Abstract available

  35. MAILATH-POKORNY M, Schwameis R, Grimm C, Reinthaller A, et al
    Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature.
    BMC Pregnancy Childbirth. 2016;16:74.
    Abstract    

    Abstract available

  36. RODRIGUES MJ, Zapardiel I, Frelaut M, Brain E, et al
    A call for specific geriatric data on cervical cancers.
    Future Oncol. 2016;12:1101-4.
    Abstract    



  37. CHENG YX, Zhang QF, Hong L, Pan F, et al
    MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma.
    Mol Med Rep. 2016;13:3155-60.
    Abstract    

    Abstract available

  38. KAUR S, Sahambi JS
    Curvelet initialized level set cell segmentation for touching cells in low contrast images.
    Comput Med Imaging Graph. 2016;49:46-57.
    Abstract    

    Abstract available

  39. BAO HL, Fang LW, Wang LH
    [The strategy for establishment of comprehensive cervical cancer prevention and control in the world].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51:96-100.
    Abstract    

    Abstract available

  40. NARASAPPA MG, Gururajachar JM, Chokkanna VK, Somashekar M, et al
    Does fall in serum glutathione predict the long-term outcome to concurrent chemoradiation for cervical cancer patients?
    J Cancer Res Ther. 2016;12:1167-1171.
    Abstract    

    Abstract available

  41. PEREZ-ROJAS JM, Gonzalez-Macias R, Gonzalez-Cortes J, Jurado R, et al
    Synergic Effect of alpha-Mangostin on the Cytotoxicity of Cisplatin in a Cervical Cancer Model.
    Oxid Med Cell Longev. 2016;2016:7981397.
    Abstract    

    Abstract available

  42. MAGUIRE RL, Vidal AC, Murphy SK, Hoyo C, et al
    Disparities in Cervical Cancer Incidence and Mortality: Can Epigenetics Contribute to Eliminating Disparities?
    Adv Cancer Res. 2017;133:129-156.
    Abstract    

    Abstract available

  43. CHEN W, Bai P, Pan J, Xu Y, et al
    Changes in Tumor Volumes and Spatial Locations Relative to Normal Tissues During Cervical Cancer Radiotherapy Assessed by Cone Beam Computed Tomography.
    Technol Cancer Res Treat. 2017 Jan 1:1533034616685942.
    Abstract    

    Abstract available

  44. FAN Y, Chen J
    Clinicopathological significance of survivin expression in patients with cervical cancer: A systematic meta-analysis.
    Bioengineered. 2017 Jan 4:1-13. doi: 10.1080/21655979.2016.1252879.
    Abstract    

    Abstract available

  45. NG JS, Ismail-Pratt I
    Cervical cancer prevention training in South East Asian LMICs.
    Gynecol Oncol Rep. 2016;19:13-17.
    Abstract    

    Abstract available

  46. KASTING ML, Wilson S, Zollinger TW, Dixon BE, et al
    Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses.
    Prev Med Rep. 2016;5:169-174.
    Abstract    

    Abstract available

  47. DEL MISTRO A, Frayle H, Ferro A, Fantin G, et al
    Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round.
    Prev Med Rep. 2016;5:166-168.
    Abstract    

    Abstract available

  48. BERNARDES-OLIVEIRA E, Gomes DL, Martelli Palomino G, Juvenal Silva Farias K, et al
    Bothrops jararaca and Bothrops erythromelas Snake Venoms Promote Cell Cycle Arrest and Induce Apoptosis via the Mitochondrial Depolarization of Cervical Cancer Cells.
    Evid Based Complement Alternat Med. 2016;2016:1574971.
    Abstract    

    Abstract available

  49. YAMAMOTO Y, Watanabe K, Matsushita H, Tsukiyama I, et al
    The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone.
    Yakugaku Zasshi. 2017;137:79-82.
    Abstract    

    Abstract available

  50. ZHANG JY, Hong DL
    SU-F-I-03: Correction of Intra-Fractional Set-Up Errors and Target Coverage Based On Cone-Beam Computed Tomography for Cervical Cancer Patients.
    Med Phys. 2016;43:3387.
    Abstract    

    Abstract available

  51. KISLING K, Zhang L, Yang J, Jhingran A, et al
    SU-F-T-423: Automating Treatment Planning for Cervical Cancer in Low- and Middle- Income Countries.
    Med Phys. 2016;43:3560.
    Abstract    

    Abstract available

  52. MIYASAKA Y, Kadoya N, Kuroda Y, Ito K, et al
    TU-AB-202-02: Deformable Image Registration Accuracy Between External Beam Radiotherapy and HDR Brachytherapy CT Images for Cervical Cancer Using a 3D-Printed Deformable Pelvis Phantom.
    Med Phys. 2016;43:3736-3737.
    Abstract    

    Abstract available

  53. ZHANG JY, Hong DL
    SU-F-T-397: Evaluating the Impact of Bladder Filling Status for the Organs at Risk Dose Distribution in Cervical Cancer Patients with Intensity Modulated Radiotherapy.
    Med Phys. 2016;43:3554.
    Abstract    

    Abstract available

  54. MWIDU U, Devic S, Shehadeh M, AlKafi M, et al
    SU-F-T-420: Dosimetry Comparison of Advanced External Beam Radiation Treatment Modalities to Brachytherapy Treatments in Patients with Cervical Cancer.
    Med Phys. 2016;43:3559.
    Abstract    

    Abstract available

  55. RAMANUJAM N
    WE-FG-201-01: Patient Centric Technologies for Diagnosis of Breast and Cervical Cancer.
    Med Phys. 2016;43:3822.
    Abstract    

    Abstract available

  56. SANTORO J, Witten M, Haas J
    SU-F-T-633: Cyberknife Boost Versus Conventional Tandem and Ovoid Treatment for Cervical Cancer.
    Med Phys. 2016;43:3609.
    Abstract    

    Abstract available

  57. ZHEN X, Chen H, Liao Y, Zhou L, et al
    SU-F-J-217: Accurate Dose Volume Parameters Calculation for Revealing Rectum Dose-Toxicity Effect Using Deformable Registration in Cervical Cancer Brachytherapy: A Pilot Study.
    Med Phys. 2016;43:3458.
    Abstract    

    Abstract available

  58. SOLIMAN A, Han D, Elzibak A, Safigholi H, et al
    SU-G-IeP1-09: MRI Evaluation of a Direction-Modulated Brachytherapy (DMBT) Tandem Applicator for Cervical Cancer On 3T.
    Med Phys. 2016;43:3646.
    Abstract    

    Abstract available

  59. LIANG X, Zheng D, Zhang X, Narayanasamy G, et al
    SU-F-T-14: Dosimetric Impacts of Various Uncertainties in Cervical Cancer HDR Brachytherapy: Are Conventional Point Doses Good Surrogates for 3D Dosimetry?
    Med Phys. 2016;43:3464.
    Abstract    

    Abstract available

  60. ZHANG H
    SU-F-T-38: How Much Dose Is Given in MR Guided Cervical Cancer Brachytherapy with the Ring and Tandem Applicators?
    Med Phys. 2016;43:3470.
    Abstract    

    Abstract available

  61. MEERSCHAERT R, Paul A, Chen W, Miller S, et al
    WE-AB-207B-04: A Preliminary Investigation of Indicators for Treatment Outcomes of CT Guided Cervical Cancer Brachytherapy.
    Med Phys. 2016;43:3804-3805.
    Abstract    

    Abstract available

  62. LIU X, Yin Y, Lin X
    SU-F-T-440: The Feasibility Research of Checking Cervical Cancer IMRT Pre- Treatment Dose Verification by Automated Treatment Planning Verification System.
    Med Phys. 2016;43:3564.
    Abstract    

    Abstract available

  63. SAFIGHOLI H, Han D, Mashouf S, Soliman A, et al
    WE-DE-201-03: Combined Use of 192Ir, 60Co, and 169Yb Sources with the Novel Direction Modulated Brachytherapy Tandem Applicator for High Dose Rate Brachytherapy Planning of Cervical Cancer.
    Med Phys. 2016;43:3808-3809.
    Abstract    

    Abstract available

  64. KAMIO Y, Barkati M, Beliveau-Nadeau D
    TH-AB-BRA-04: Dosimetric Evaluation of MR-Guided HDR Brachytherapy Planning for Cervical Cancer.
    Med Phys. 2016;43:3854.
    Abstract    

    Abstract available

  65. CHEN X, Wang J, Hu W
    SU-F-T-355: Evaluation of Knowledge-Based Planning Model for the Cervical Cancer Radiotherapy.
    Med Phys. 2016;43:3545.
    Abstract    

    Abstract available

  66. LEE E, Yuan F, Templeton A, Yao R, et al
    WE-AB-207B-11: Optimizing Tumor Control Probability in Radiation Therapy Treatment - Application to HDR Cervical Cancer.
    Med Phys. 2016;43:3806.
    Abstract    

    Abstract available

  67. DELGADO AB, Cohen D, Eng T, Gutierrez A, et al
    SU-F-T-590: Modeling PTV Dose Fall-Off for Cervical Cancer SBRT Treatment Planning Using VMAT and Step-And-Shoot IMRT.
    Med Phys. 2016;43:3599.
    Abstract    

    Abstract available

  68. MEERSCHAERT R, Nalichowski A, Burmeister J, Paul A, et al
    SU-C-202-02: A Comprehensive Evaluation of Adaptive Daily Planning for Cervical Cancer HDR Brachytherapy.
    Med Phys. 2016;43:3323.
    Abstract    

    Abstract available

  69. ZHANG R, Bai W, Fan X
    SU-F-P-29: Impact of Oral Contrast Agent for Assisting in Outlining Small Intestine On Pelvic IMAT Dose in Patients with Cervical Cancer.
    Med Phys. 2016;43:3364.
    Abstract    

    Abstract available

  70. GAVRILESCU MM, Hutanu I, Ioanid N, Musina AM, et al
    Clinical Value of Hematological Biomarkers in Uterine Cervical Cancer.
    Chirurgia (Bucur). 2016;111:493-499.
    Abstract    

    Abstract available

  71. SANTOS PA, Avanco GB, Nerilo SB, Marcelino RI, et al
    Assessment of Cytotoxic Activity of Rosemary (Rosmarinus officinalis L.), Turmeric (Curcuma longa L.), and Ginger (Zingiber officinale R.) Essential Oils in Cervical Cancer Cells (HeLa).
    ScientificWorldJournal. 2016;2016:9273078.
    Abstract    

    Abstract available

  72. MOHAMMADI BEZANAJ F, Sadeghi Evari M
    Cervical cancer screening problem: The social and cultural matters in Iran.
    J BUON. 2016;21:1563-1564.
    Abstract    



  73. ZHANG M, Li N, Liang Y, Liu J, et al
    Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer.
    Int J Clin Oncol. 2016 Dec 30. doi: 10.1007/s10147-016-1077.
    Abstract    

    Abstract available

  74. SILVA E SILVA A, Fernandes RP, Araujo MP, Carvalho JP, et al
    Single-Site Robotic Radical Hysterectomy and Sentinel Lymphnode Biopsy in Cervical Cancer: A Case Report.
    Rev Bras Ginecol Obstet. 2016 Dec 30. doi: 10.1055/s-0036-1597752.
    Abstract    

    Abstract available

  75. WONG G, Hayward JS, McArthur E, Craig JC, et al
    Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.
    Clin J Am Soc Nephrol. 2016 Dec 29. pii: CJN.05990616. doi: 10.2215/CJN.05990616
    Abstract    

    Abstract available

  76. ISIDEAN SD, Shinder GA
    Changes on the horizon for cervical cancer screening.
    Prev Med. 2016 Dec 27. pii: S0091-7435(16)30442.
    Abstract    



  77. LINDBLOM E, Dasu A, Beskow C, Toma-Dasu I, et al
    High brachytherapy doses can counteract hypoxia in cervical cancer-a modelling study.
    Phys Med Biol. 2016;62:560-572.
    Abstract    

    Abstract available

  78. THONGSAK N, Chitapanarux I, Suprasert P, Prasitwattanaseree S, et al
    Spatial and Temporal Analyses of Cervical Cancer Patients in Upper Northern Thailand
    Asian Pac J Cancer Prev. 2016;17:5011-5017.
    Abstract    

    Abstract available

  79. ASGARLOU Z, Tehrani S, Asghari E, Arzanlou M, et al
    Cervical Cancer Prevention Knowledge and Attitudes among Female University Students and Hospital Staff in Iran
    Asian Pac J Cancer Prev. 2016;17:4921-4927.
    Abstract    

    Abstract available

  80. COMITATO R, Guantario B, Leoni G, Nesaretnam K, et al
    Tocotrienols induce endoplasmic reticulum stress and apoptosis in cervical cancer cells.
    Genes Nutr. 2016;11:32.
    Abstract    

    Abstract available

  81. JAYANT K, Sankaranarayanan R, Thorat RV, Muwonge R, et al
    Improved Survival of Cervical Cancer Patients in a Screened Population in Rural India
    Asian Pac J Cancer Prev. 2016;17:4837-4844.
    Abstract    

    Abstract available

  82. NASAR A, Waad A, Atheer A, Nasra A, et al
    Awareness of Cervical Cancer and Pap Smear Testing Among Omani Women
    Asian Pac J Cancer Prev. 2016;17:4825-4830.
    Abstract    

    Abstract available

  83. BOAVENTURA CS, Galvao JL, Soares GM, Bitencourt AG, et al
    Synchronous gynecologic cancer and the use of imaging for diagnosis.
    Rev Assoc Med Bras (1992). 2016;62:116-9.
    Abstract    

    Abstract available

  84. MERY B, Ndong SM, Guy JB, Assouline A, et al
    Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms.
    Chin J Cancer. 2016;35:43.
    Abstract    

    Abstract available

  85. EWAISHA R, Meshay I, Resnik J, Katchman BA, et al
    Programmable protein arrays for immunoprofiling HPV-associated cancers.
    Proteomics. 2016;16:1215-24.
    Abstract    

    Abstract available

  86. LI J, Wang YY, Nan X, Tian XF, et al
    Prevalence of human papillomavirus genotypes among women with cervical lesions in the Shaanxi Province of China.
    Genet Mol Res. 2016;15.
    Abstract    

    Abstract available

  87. SHON W, Wada DA, Kalaaji AN
    Radiation-induced pemphigus or pemphigoid disease in 3 patients with distinct underlying malignancies.
    Cutis. 2016;97:219-22.
    Abstract    

    Abstract available

  88. SARDAIN H, Lavoue V, Foucher F, Leveque J, et al
    [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
    J Gynecol Obstet Biol Reprod (Paris). 2016;45:315-29.
    Abstract    

    Abstract available

  89. TOPALIS D, Nogueira TC, De Schutter T, El Amri C, et al
    Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1.
    Oncotarget. 2016;7:10386-401.
    Abstract    

    Abstract available

  90. SRIRAMAN SK, Pan J, Sarisozen C, Luther E, et al
    Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Mol Pharm. 2016;13:428-37.
    Abstract    

    Abstract available

  91. OKAME S, Kojima A, Teramoto N, Shiroyama Y, et al
    Type C2 radical hysterectomy may improve outcomes of locally advanced mucinous adenocarcinoma of the uterine cervix.
    Int J Clin Oncol. 2016;21:723-9.
    Abstract    

    Abstract available

  92. TANAKA Y, Ueda Y, Kakuda M, Kubota S, et al
    Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.
    Int J Clin Oncol. 2016;21:730-4.
    Abstract    

    Abstract available

  93. BASU P, Banerjee D, Mittal S, Dutta S, et al
    Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.
    J Med Virol. 2016;88:1271-8.
    Abstract    

    Abstract available

  94. TOSTESON AN, Beaber EF, Tiro J, Kim J, et al
    Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    J Gen Intern Med. 2016;31:372-9.
    Abstract    

    Abstract available

  95. BRIE C, Turck M, Cheret A, Morello R, et al
    [Case-control study of obstetrical outcomes of conisation].
    J Gynecol Obstet Biol Reprod (Paris). 2016;45:192-7.
    Abstract    

    Abstract available

  96. DIAZ A, Kang J, Moore SP, Baade P, et al
    Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis.
    Cancer Epidemiol. 2017;47:7-19.
    Abstract    

    Abstract available

  97. TAO T, Yang X, Qin Q, Shi W, et al
    NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  98. HOFSJO A, Bohm-Starke N, Blomgren B, Jahren H, et al
    Radiotherapy-induced vaginal fibrosis in cervical cancer survivors.
    Acta Oncol. 2017 Jan 13:1-9. doi: 10.1080/0284186X.2016.1275778.
    Abstract    

    Abstract available

  99. ZHOU Y, An Q, Guo RX, Qiao YH, et al
    miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway.
    Life Sci. 2017 Jan 9. pii: S0024-3205(17)30006-1. doi: 10.1016/j.lfs.2017.
    Abstract    

    Abstract available

  100. SU Z, Yang H, Zhao M, Wang Y, et al
    MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
    Oncol Res. 2017;25:137-145.
    Abstract    

    Abstract available

  101. CHAN DN, So WK
    A Systematic Review of the Factors Influencing Ethnic Minority Women's Cervical Cancer Screening Behavior: From Intrapersonal to Policy Level.
    Cancer Nurs. 2017 Jan 9. doi: 10.1097/NCC.0000000000000436.
    Abstract    

    Abstract available

  102. FU ZZ, Li K, Peng Y, Zheng Y, et al
    Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer: A network meta-analysis.
    Medicine (Baltimore). 2017;96:e5853.
    Abstract    

    Abstract available

  103. YEUNG CL, Tsang TY, Yau PL, Kwok TT, et al
    Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
    Oncotarget. 2017 Jan 6. doi: 10.18632/oncotarget.14555.
    Abstract    

    Abstract available

  104. WU J, Chen M, Liang C, Su W, et al
    Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.
    Oncotarget. 2017 Jan 6. doi: 10.18632/oncotarget.14541.
    Abstract    

    Abstract available

  105. SONG Z, Zhang X, Ye X, Feng C, et al
    High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-kappaB Predicts Poor Prognosis in Cervical Cancer.
    Med Sci Monit. 2017;23:151-157.
    Abstract    

    Abstract available

  106. DANG YZ, Zhang Y, Li JP, Hu J, et al
    High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer.
    Medicine (Baltimore). 2017;96:e5772.
    Abstract    

    Abstract available

  107. YUAN Z, Chen D, Chen X, Yang H, et al
    Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells.
    Cancer Cell Int. 2017;17:7.
    Abstract    

    Abstract available

  108. LIU P, Iden M, Fye S, Huang YW, et al
    Targeted, deep sequencing reveals full methylation profiles of multiple HPV types and potential biomarkers for cervical cancer progression.
    Cancer Epidemiol Biomarkers Prev. 2017 Jan 9. pii: cebp.0368.2016.
    Abstract    

    Abstract available

  109. XU Y, Zhu L, Ru T, Wang H, et al
    Three-dimensional power Doppler ultrasound in the early assessment of response to concurrent chemo-radiotherapy for advanced cervical cancer.
    Acta Radiol. 2017 Jan 1:284185116684677. doi: 10.1177/0284185116684677.
    Abstract    

    Abstract available

  110. ZAHEER R, Alam N, Faqir Hussain KC, Herekar AA, et al
    Awareness about human papillomavirus as a cause of cervical cancer and its prevention in the undergraduate female students of Karachi.
    J Pak Med Assoc. 2017;67:27-32.
    Abstract    

    Abstract available

  111. FERREIRA MP, Coghill AE, Chaves CB, Bergmann A, et al
    Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001-2013).
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001367.
    Abstract    

    Abstract available

  112. ENWERE EK, Kornaga EN, Dean M, Koulis TA, et al
    Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer.
    Mod Pathol. 2017 Jan 6. doi: 10.1038/modpathol.2016.
    Abstract    

    Abstract available

  113. XU H, Yuan Y, Ji JY, Jiang Q, et al
    [Effect of Rab11 gene expression on the invasion and migration of cervical cancer cell line SiHa in hypoxia].
    Zhonghua Fu Chan Ke Za Zhi. 2016;51:928-933.
    Abstract    

    Abstract available

  114. ZHANG J, Lin Z, Gao Y, Yao T, et al
    Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
    J Exp Clin Cancer Res. 2017;36:5.
    Abstract    

    Abstract available

  115. SUI M, Pei Y, Li D, Li Q, et al
    Misdiagnosis Analysis of Cervical Minimal Deviation Adenocarcinoma: a Report of Three Rare Cases and Literature Review.
    Ann Clin Lab Sci. 2016;46:680-690.
    Abstract    

    Abstract available

  116. ROTAR IC, Dumitras DE, Popp RA, Petrisor FM, et al
    VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia.
    Anal Cell Pathol (Amst). 2016;2016:6074275.
    Abstract    

    Abstract available

  117. LU YY, Lu CH, Wang HY
    Clitoral Metastasis From Advanced Cervical Carcinoma on 18F-FDG-PET/CT.
    Clin Nucl Med. 2016.
    Abstract    

    Abstract available

  118. LI QL, Ding L, Nan J, Liu CL, et al
    [Relationship and interaction between folate and expression of methyl-CpG-binding protein 2 in cervical cancerization].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37:985-91.
    Abstract    

    Abstract available

  119. SHIMADA M, Nagao S, Fujiwara K, Takeshima N, et al
    Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
    Int J Clin Oncol. 2016;21:1128-1135.
    Abstract    

    Abstract available

  120. DUAN J, Meng X, Liu T, Yin Y, et al
    Capability of leaf interdigitation with different inverse planning strategies in Monaco: an investigation of representative tumour sites.
    Radiat Oncol. 2016;11:82.
    Abstract    

    Abstract available

  121. CHUDGAR AV, Mulugeta PG, Chauhan A, Dubroff JG, et al
    Uterine Cervical Metastasis From Primary Rectal Adenocarcinoma on PET/CT and MRI.
    Clin Nucl Med. 2016.
    Abstract    

    Abstract available

  122. JIN RR, Ma HW, Chen TY, Zhang ZH, et al
    [Research progress on triage of ASC-US in cervical cytology].
    Zhonghua Bing Li Xue Za Zhi. 2016;45:427-30.
    Abstract    



  123. YASSIN AM, Elnouby M, El-Deeb NM, Hafez EE, et al
    Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
    Appl Biochem Biotechnol. 2016;180:623-637.
    Abstract    

    Abstract available

  124. YUAN GW, Yao HW, Li XG, Li HJ, et al
    [Analysis of 13 cases of rhabdomyosarcoma in the female genital tract].
    Zhonghua Fu Chan Ke Za Zhi. 2016;51:264-9.
    Abstract    

    Abstract available

  125. FANG WH, Yen CF, Hu J, Lin JD, et al
    The utilization and barriers of Pap smear among women with visual impairment.
    Int J Equity Health. 2016;15:65.
    Abstract    

    Abstract available

  126. NISHIMOTO K, Akise Y, Miyazawa M, Kutsuki S, et al
    A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine.
    Keio J Med. 2016;65:16-20.
    Abstract    

    Abstract available

  127. ALTENBURG A, Abdel-Naser MB, Nikolakis G, Wild T, et al
    CD40/CD40 ligand interactions and TNFalpha treatment reduce activity of P105 promoter of the human papilloma virus-18 in vitro.
    Exp Oncol. 2016;38:22-5.
    Abstract    

    Abstract available

  128. BADIGA S, Siddiqui NR, Macaluso M, Johanning GL, et al
    Homocysteinemia is Associated with a Lower Degree of PBMC LINE-1 Methylation and a Higher Risk of CIN 2C in the U.S. Post-Folic Acid Fortification Era.
    Nutr Cancer. 2016;68:446-55.
    Abstract    

    Abstract available

  129. FENNELL J, Scholber J, Grosu AL, Volegova-Neher N, et al
    MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective.
    Q J Nucl Med Mol Imaging. 2016;60:117-23.
    Abstract    

    Abstract available

  130. OIKE T, Niimi A, Okonogi N, Murata K, et al
    Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy.
    Sci Rep. 2016;6:22275.
    Abstract    

    Abstract available

  131. BLAIN G, Richards A, Pather S, Carter J, et al
    A retrospective observational study for the outcomes of women presenting to a colposcopy clinic with a high-grade Pap smear - Implications for a 'see and treat' approach to management.
    Aust N Z J Obstet Gynaecol. 2016;56:207-11.
    Abstract    

    Abstract available

  132. BARBOZA GE, Dominguez S
    A sequential logit model of caretakers' decision to vaccinate children for the human papillomavirus virus in the general population.
    Prev Med. 2016;85:84-9.
    Abstract    

    Abstract available

  133. NIYAZI M, Husaiyin S, Han L, Mamat H, et al
    Prevalence of and risk factors for high-risk human papillomavirus infection: a population-based study from Hetian, Xinjiang, China.
    Bosn J Basic Med Sci. 2016;16:46-51.
    Abstract    

    Abstract available

  134. LIU F, Tong D, Li H, Liu M, et al
    Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin alpha2/beta5/FAK signaling pathway.
    Oncotarget. 2016;7:8896-907.
    Abstract    

    Abstract available

  135. CIAVATTINI A, Sopracordevole F, Di Giuseppe J, Lucarini G, et al
    Glycodelin expression in pregnant patients with cervical intraepithelial neoplasia: a case-control study.
    Gynecol Endocrinol. 2015.
    Abstract    

    Abstract available

  136. KUDOH A, Sato S, Itamochi H, Komatsu H, et al
    Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
    Int J Clin Oncol. 2016;21:580-7.
    Abstract    

    Abstract available

  137. LAPUZ C, Kondalsamy-Chennakesavan S, Bernshaw D, Khaw P, et al
    Stage IB cervix cancer with nodal involvement treated with primary surgery or primary radiotherapy: Patterns of failure and outcomes in a contemporary population.
    J Med Imaging Radiat Oncol. 2016;60:274-82.
    Abstract    

    Abstract available

  138. KOLA-PALMER S, Walsh JC, Rogers M
    Patients' perceptions of colposcopy pain.
    Eur J Cancer Care (Engl). 2016;25:49-56.
    Abstract    

    Abstract available

  139. ASGARY R, Naderi R, Wisnivesky J
    Opt-Out Patient Navigation to Improve Breast and Cervical Cancer Screening Among Homeless Women.
    J Womens Health (Larchmt). 2017 Jan 19. doi: 10.1089/jwh.2016.6066.
    Abstract    

    Abstract available

  140. ROYCHOWDHURY A, Samadder S, Islam MS, Chaudhury K, et al
    Identification of Changes in the Human Papilloma Virus 16 (HPV16) Genome During Early Dissemination of Cervical Cancer Cells May Complement Histological Diagnosis of Lymph Node Metastasis.
    Pathol Oncol Res. 2017 Jan 19. doi: 10.1007/s12253-017-0189.
    Abstract    

    Abstract available

  141. MORENO-ACOSTA P, Carrillo S, Gamboa O, Romero-Rojas A, et al
    Novel predictive biomarkers for cervical cancer prognosis.
    Mol Clin Oncol. 2016;5:792-796.
    Abstract    

    Abstract available

  142. BAO HL, Liu YN, Wang LJ, Fang LW, et al
    [Analysis on mortality of cervical cancer and its temporal trend in women in China, 2006-2012].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:58-64.
    Abstract    

    Abstract available

  143. DONG L, Hu SY, Zhang Q, Feng RM, et al
    [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:20-25.
    Abstract    

    Abstract available

  144. SOBCZYK K, Wozniak-Holecka J, Holecki T, Szalabska D, et al
    The organization and financing of cervical cancer prevention carried out by midwives in primary health care.
    Ginekol Pol. 2016;87:798-804.
    Abstract    

    Abstract available

  145. BERRY L
    Cervical cancer.
    Nurs Stand. 2017;31:15.
    Abstract    

    Abstract available


  146. Correction to "Berberine Reverses Epithelial-to-Mesenchymal Transition and Inhibits Metastasis and Tumor-Induced Angiogenesis in Human Cervical Cancer Cells".
    Mol Pharmacol. 2017;91:158.
    Abstract    



  147. ISIDEAN SD, Mayrand MH, Ramanakumar AV, Rodrigues I, et al
    COMPARISON OF TRIAGE STRATEGIES FOR HPV POSITIVE WOMEN: CANADIAN CERVICAL CANCER SCREENING TRIAL RESULTS.
    Cancer Epidemiol Biomarkers Prev. 2017 Jan 17. pii: cebp.0705.2016.
    Abstract    

    Abstract available

  148. CHAPMAN LAMBERT CL, Azuero A, Enah CC, McMillan SC, et al
    A psychometric examination of an instrument to measure the dimensions of Champion's Health Belief Model Scales for cervical cancer screening in women living with HIV.
    Appl Nurs Res. 2017;33:78-84.
    Abstract    

    Abstract available

  149. LI N, Wang Y, Che S, Yang Y, et al
    HBXIP over expression as an independent biomarker for cervical cancer.
    Exp Mol Pathol. 2017 Jan 13. pii: S0014-4800(16)30260.
    Abstract    

    Abstract available

  150. HU Y, Sun X, Mao C, Guo G, et al
    Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration.
    Cancer Med. 2017 Jan 15. doi: 10.1002.
    Abstract    

    Abstract available

  151. BARQUET-MUNOZ SA, Rendon-Pereira GJ, Acuna-Gonzalez D, Penate MV, et al
    Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer.
    World J Surg Oncol. 2017;15:23.
    Abstract    

    Abstract available

  152. ESCARRA-SENMARTI M, Bueno-Topete MR, Jave-Suarez LF, Gomez-Banuelos E, et al
    Loss of CD28 within CD4+ T cell subsets from cervical cancer patients is accompanied by the acquisition of intracellular perforin, and is further enhanced by NKG2D expression.
    Immunol Lett. 2017;182:30-38.
    Abstract    

    Abstract available

  153. KOBETZ E, Seay J, Amofah A, Pierre L, et al
    Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial.
    Trials. 2017;18:19.
    Abstract    

    Abstract available

  154. MITCHELL SM, Pedersen HN, Eng Stime E, Sekikubo M, et al
    Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
    BMC Womens Health. 2017;17:4.
    Abstract    

    Abstract available

  155. KASSEM L, Abdel-Rahman O
    Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data.
    Crit Rev Oncol Hematol. 2016;108:1-12.
    Abstract    

    Abstract available

  156. WANG Y, Wang S, Shen J, Peng Y, et al
    Genotype Distribution of Human Papillomavirus among Women with Cervical Cytological Abnormalities or Invasive Squamous Cell Carcinoma in a High-Incidence Area of Esophageal Carcinoma in China.
    Biomed Res Int. 2016;2016:1256384.
    Abstract    

    Abstract available

  157. SCHNEIDER J, Eiro N, Perez-Fernandez R, Martinez-Ordonez A, et al
    Human Uterine Cervical Stromal Stem Cells (hUCESCs): Why and How they Exert their Antitumor Activity.
    Cancer Genomics Proteomics. 2016;13:331-7.
    Abstract    

    Abstract available

  158. SUN JH
    [New challenges to the treatment of cervical intraepithelial neoplasia].
    Zhonghua Zhong Liu Za Zhi. 2016;38:556-7.
    Abstract    

    Abstract available

  159. ATCI N, Ozgur T, Ozturk F, Dolapcioglu KS, et al
    Utility of intravaginal ultrasound gel for local staging of cervical carcinoma on MRI.
    Clin Imaging. 2016;40:1104-1107.
    Abstract    

    Abstract available

  160. ZHOU W, Hua F, Zuo C, Guan Y, et al
    Primary Uterine Cervical Lymphoma Manifesting as Menolipsis Staged and Followed Up by FDG PET/CT.
    Clin Nucl Med. 2016.
    Abstract    

    Abstract available

  161. DANIAL M, Sivasangari S, Arulappen A, Ong L, et al
    Journey of the Human Papillomavirus (HPV) in a Developing Country over 5 Years (2010 - 2015).
    Asian Pac J Cancer Prev. 2016;17:1363-8.
    Abstract    

    Abstract available

  162. GHAHREMANI L, Harami ZK, Kaveh MH, Keshavarzi S, et al
    Investigation of the Role of Training Health Volunteers in Promoting Pap Smear Test Use among Iranian Women Based on the Protection Motivation Theory.
    Asian Pac J Cancer Prev. 2016;17:1157-62.
    Abstract    

    Abstract available

  163. NGAMKHAM J, Boonmark K, Phansri T
    Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
    Asian Pac J Cancer Prev. 2016;17:1129-34.
    Abstract    

    Abstract available

  164. SABEENA S, Bhat P, Kamath V, Mathew M, et al
    Detection of Genital HPV Infection Using Urine Samples: a Population Based Study in India.
    Asian Pac J Cancer Prev. 2016;17:1083-8.
    Abstract    

    Abstract available

  165. ZHOU J, Yang HY, Wu SG, He ZY, et al
    The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
    Cancer Med. 2016;5:1108-15.
    Abstract    

    Abstract available

  166. ZHOU TJ, Huang XH, Gong L, Xiang L, et al
    Vasculogenic mimicry and hypoxia-inducible factor-1alpha expression in cervical squamous cell carcinoma.
    Genet Mol Res. 2016;15:15017396.
    Abstract    

    Abstract available

  167. BACHELET VC
    Two doses and not three for the human papilloma virus vaccine in Chile.
    Medwave. 2016;16:e6373.
    Abstract    



  168. CHUNG JH, So MW, Kim SG
    Paraneoplastic dermatomyositis presenting myopathy combined with synchronous cervical and sigmoid colon cancer.
    Korean J Intern Med. 2016;31:413-6.
    Abstract    



  169. PANDURANGAN M, Nagajyothi PC, Shim J, Kim DH, et al
    Anti-Proliferative Effect of Copper Oxide Nanorods Against Human Cervical Carcinoma Cells.
    Biol Trace Elem Res. 2016;173:62-70.
    Abstract    

    Abstract available

  170. CHIKAZAWA K, Netsu S, Motomatsu S, Konno R, et al
    Predictors of recurrent/residual disease after loop electrosurgical excisional procedure.
    J Obstet Gynaecol Res. 2016;42:457-63.
    Abstract    

    Abstract available

  171. POMEL C, Martinez A, Bourgin C, Beguinot M, et al
    Survival effect of laparoscopic para-aortic staging in locally advanced cervical cancer: a retrospective cohort analysis.
    BJOG. 2017 Jan 27. doi: 10.1111/1471-0528.14492.
    Abstract    

    Abstract available

  172. FENG H, Sui L, Du M, Wang Q, et al
    Meta-analysis of TP73 polymorphism and cervical cancer.
    Genet Mol Res. 2017;16.
    Abstract    

    Abstract available

  173. YOSHIZAWA E, Koiwai K, Ina H, Fukazawa A, et al
    Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases.
    J Obstet Gynaecol Res. 2017 Jan 26. doi: 10.1111/jog.13259.
    Abstract    

    Abstract available

  174. TSENG OL, Spinelli JJ, Dawes M, McBride ML, et al
    Cervical cancer screening for survivors diagnosed with cancer before age 25.
    J Cancer Surviv. 2017 Jan 27. doi: 10.1007/s11764-017-0598.
    Abstract    

    Abstract available

  175. TAX C, Steenbergen ME, Zusterzeel PL, Bekkers RL, et al
    Measuring health-related quality of life in cervical cancer patients: a systematic review of the most used questionnaires and their validity.
    BMC Med Res Methodol. 2017;17:15.
    Abstract    

    Abstract available

  176. GOLDFARB RA, Fan Y, Jarosek S, Elliott SP, et al
    The burden of chronic ureteral stenting in cervical cancer survivors.
    Int Braz J Urol. 2017;43:104-111.
    Abstract    

    Abstract available

  177. XIE Y, Tan X, Shao H, Liu Q, et al
    VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
    BMC Public Health. 2017;17:118.
    Abstract    

    Abstract available

  178. LI Y, Zhang Z, Xiao Z, Lin Y, et al
    Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
    Oncotarget. 2017 Jan 19. doi: 10.18632/oncotarget.14738.
    Abstract    

    Abstract available

  179. LI X, Huang K, Zhang Q, Zhou J, et al
    Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.
    Sci Rep. 2017;7:41103.
    Abstract    

    Abstract available

  180. LUTKOWSKA A, Roszak A, Lianeri M, Sowinska A, et al
    Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression.
    Mol Diagn Ther. 2017 Jan 25. doi: 10.1007/s40291-017-0256.
    Abstract    

    Abstract available

  181. GILBERT ES, Curtis RE, Hauptmann M, Kleinerman RA, et al
    Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.
    Radiat Res. 2017 Jan 24. doi: 10.1667/RR14453.
    Abstract    

    Abstract available

  182. PANICH T, Tragoolpua K, Pata S, Tayapiwatana C, et al
    Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
    Cancer Biother Radiopharm. 2017 Jan 24. doi: 10.1089/cbr.2016.2126.
    Abstract    

    Abstract available

  183. PEREIRA E, Cooper HH, Zelaya PG, Creasman W, et al
    Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting.
    Gynecol Oncol Rep. 2016;19:50-52.
    Abstract    

    Abstract available

  184. OTTER S, Franklin A, Ajaz M, Stewart A, et al
    Improving the efficiency of image guided brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2016;8:557-565.
    Abstract    

    Abstract available

  185. PERRUCCI E, Lancellotta V, Benedetto MD, Palumbo I, et al
    Encrusted cystitis after definitive radiotherapy for cervical cancer: a case report.
    J Contemp Brachytherapy. 2016;8:541-543.
    Abstract    

    Abstract available

  186. KUO HC, Mehta KJ, Yaparpalvi R, Shankar V, et al
    Model assessment of individual tumor control rate and adverse effects in comparing locally advanced cervical cancer treatment using intracavitary with and without interstitial brachytherapy.
    J Contemp Brachytherapy. 2016;8:525-532.
    Abstract    

    Abstract available

  187. VINCERZEVSKIENE I, Jasilionis D, Austys D, Stukas R, et al
    Education predicts cervical cancer survival: a Lithuanian cohort study.
    Eur J Public Health. 2017 Jan 23. pii: ckw261. doi: 10.1093.
    Abstract    

    Abstract available

  188. WONG EL, Cheung AW, Huang F, Chor JS, et al
    Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Cancer Nurs. 2017 Jan 20. doi: 10.1097/NCC.0000000000000462.
    Abstract    

    Abstract available


  189. Integrated genomic and molecular characterization of cervical cancer.
    Nature. 2017 Jan 23. doi: 10.1038/nature21386.
    Abstract    

    Abstract available

  190. ZHOU X, Yue Y, Wang R, Gong B, et al
    MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
    Int J Oncol. 2017 Jan 19. doi: 10.3892/ijo.2017.3857.
    Abstract    

    Abstract available

  191. SHARMA G, Rana NK, Singh P, Dubey P, et al
    p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells.
    Biomed Pharmacother. 2017;88:218-231.
    Abstract    

    Abstract available

  192. MAYADEV J, Viswanathan A, Liu Y, Li CS, et al
    American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
    Brachytherapy. 2017;16:22-43.
    Abstract    

    Abstract available

  193. CHEN Y, Wang H, Lin W, Shuai P, et al
    ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
    Diagn Pathol. 2017;12:12.
    Abstract    

    Abstract available

  194. ZHAO KN, Zhang L, Qu J
    Dr. Jian Zhou: The great inventor of cervical cancer vaccine.
    Protein Cell. 2017 Jan 20. doi: 10.1007/s13238-016-0358.
    Abstract    



  195. YAMAUCHI M, Fukuda T, Wada T, Kawanishi M, et al
    Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Oncol Lett. 2016;12:5183-5189.
    Abstract    

    Abstract available

  196. YANG CX, Zhang SM, Li J, Yang B, et al
    MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting beta-catenin.
    Oncol Lett. 2016;12:4983-4990.
    Abstract    

    Abstract available

  197. WANG Y, Zhang X, Miao F, Cao Y, et al
    Clinical significance of leukocyte-associated immunoglobulin-like receptor-1 expression in human cervical cancer.
    Exp Ther Med. 2016;12:3699-3705.
    Abstract    

    Abstract available

  198. KIM TS, Lim MS, Hong YJ, Hwang SM, et al
    Significance of "Not Detected but Amplified" Results by Real-Time PCR Method for HPV DNA Detection.
    Biomed Res Int. 2016;2016:5170419.
    Abstract    

    Abstract available

  199. OCK M, Park JY, Son WS, Lee HJ, et al
    Estimation of utility weights for human papilloma virus-related health states according to disease severity.
    Health Qual Life Outcomes. 2016;14:163.
    Abstract    

    Abstract available

  200. GUI H, Guo XR, Fang J, Ma SN, et al
    The Tumor-promoting Effects of FAM92A1-289 in Cervical Carcinoma Cells.
    Anticancer Res. 2016;36:5197-5204.
    Abstract    

    Abstract available

  201. HILAL Z, Hartmann F, Dogan A, Cetin C, et al
    Lymphoma of the Cervix: Case Report and Review of the Literature.
    Anticancer Res. 2016;36:4931-40.
    Abstract    

    Abstract available

  202. PARK JS, Shin S, Kim EC, Kim JE, et al
    Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.
    APMIS. 2016;124:950-957.
    Abstract    

    Abstract available

  203. MASUKO S, Ikura Y, Kato H, Iwai Y, et al
    Blue nevus presenting as an endocervical polyp.
    Pol J Pathol. 2016;67:191-4.
    Abstract    



  204. DE ABREU AL, Gimenes F, Malaguti N, Pereira MW, et al
    Detection of Human Papillomavirus among Women with Atypical Squamous Cells of Undetermined Significance Referred to Colposcopy: Implications for Clinical Management in Low and MiddleIncome Countries.
    Asian Pac J Cancer Prev. 2016;17:3637-41.
    Abstract    

    Abstract available

  205. SENOL T, Polat M, Ozkaya E, Karateke A, et al
    Comparison of Two Step LEEP and Cold Conisation For Cervical Intraepithelial Lesions to Decrease Positive Surgical Margins.
    Asian Pac J Cancer Prev. 2016;17:3317-20.
    Abstract    

    Abstract available

  206. TANGJITGAMOL S, Kantathavorn N, Kittisiam T, Chaowawanit W, et al
    Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
    Asian Pac J Cancer Prev. 2016;17:3147-53.
    Abstract    

    Abstract available

  207. MISHRA GA, Pimple SA, Shastri SS
    Prevention of Cervix Cancer in India.
    Oncology. 2016;91 Suppl 1:1-7.
    Abstract    

    Abstract available

  208. STAMENKOVIC M, Knezevic A, Knezevic I, Kuzmanovic I, et al
    High-risk human papilloma virus genotypes in cervical carcinoma of Serbian women: Distribution and association with pathohistological findings.
    Biologicals. 2016;44:412-6.
    Abstract    

    Abstract available

  209. NAKAMURA K, Nakayama K, Ishikawa M, Katagiri H, et al
    High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical Carcinoma.
    Anticancer Res. 2016;36:2933-8.
    Abstract    

    Abstract available

  210. KITTISIAM T, Tangjitgamol S, Chaowawanit W, Khunnarong J, et al
    Knowledge and Attitudes of Bangkok Metropolitan Women towards HPV and Self-Sampled HPV Testing.
    Asian Pac J Cancer Prev. 2016;17:2445-51.
    Abstract    

    Abstract available

  211. HENG S, Sirichaisutdhikorn D
    Incidence of High Grade Squamous Intraepithelial Lesions in Patients with Atypical Squamous Cells of Undetermined Significance Papanicolaou Smears at Naresuan University Hospital.
    Asian Pac J Cancer Prev. 2016;17:2411-4.
    Abstract    

    Abstract available

  212. KUMAR D, Basu S, Parija L, Rout D, et al
    Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells.
    Biomed Pharmacother. 2016;81:31-7.
    Abstract    

    Abstract available

  213. MALEERAT P, Chumworathayi B, Kietpeerakool C, Luanratanakorn S, et al
    Post-Loop Electrosurgical Excision Procedure Complications in Srinagarind Hospital.
    Asian Pac J Cancer Prev. 2016;17:2211-5.
    Abstract    

    Abstract available

  214. SINGHAL P, Sharma U, Hussain S, Nag A, et al
    Identification of genetic variants in TNF receptor 2 which are associated with the development of cervical carcinoma.
    Biomarkers. 2016;21:665-72.
    Abstract    

    Abstract available

  215. BARTOSIK M, Durikova H, Vojtesek B, Anton M, et al
    Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA.
    Biosens Bioelectron. 2016;83:300-5.
    Abstract    

    Abstract available

  216. HUTTER JN, Decker CF
    Human papillomavirus infection.
    Dis Mon. 2016;62:294-300.
    Abstract    



  217. MICHAL M, Michal M, Miesbauerova M, Hercogova J, et al
    Penile Analogue of Stratified Mucin-Producing Intraepithelial Lesion of the Cervix: The First Described Case. A Diagnostic Pitfall.
    Am J Dermatopathol. 2016;38:e64-7.
    Abstract    

    Abstract available

  218. NAHET A, Boublenza L, Hassaine H, Masdoua N, et al
    [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].
    Bull Cancer. 2016;103:455-60.
    Abstract    

    Abstract available

  219. ANGIOLI R, Lopez S, Aloisi A, Terranova C, et al
    Ten years of HPV vaccines: State of art and controversies.
    Crit Rev Oncol Hematol. 2016;102:65-72.
    Abstract    

    Abstract available

  220. CHIARULLI P, Hebert RS
    Premature diagnostic closure in palliative medicine.
    BMJ Support Palliat Care. 2016;6:151-2.
    Abstract    



  221. STECCO A, Buemi F, Cassara A, Matheoud R, et al
    Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
    Radiol Med. 2016;121:537-45.
    Abstract    

    Abstract available

  222. LONGATTO-FILHO A
    The Role of Gynecological Cytology in the Era of Molecular Testing.
    Acta Cytol. 2016;60:499-500.
    Abstract    



  223. VALENTINE K, Vanden Broeck D, Benoy I, Truyens M, et al
    Cytology at the Time of HPV: Some Things to Think about when Discussing HPV.
    Acta Cytol. 2016;60:527-533.
    Abstract    

    Abstract available

  224. BERGERON C, von Knebel Doeberitz M
    The Role of Cytology in the 21st Century: The Integration of Cells and Molecules.
    Acta Cytol. 2016;60:540-542.
    Abstract    

    Abstract available

  225. SUGIYAMA Y, Sasaki H, Komatsu K, Yabushita R, et al
    A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
    Acta Cytol. 2016;60:451-457.
    Abstract    

    Abstract available

  226. HUI Y, Hansen K, Murthy J, Chau D, et al
    Relevance of the Pap Test: A Report of HPV-DNA Test-Negative High-Grade Squamous Intraepithelial Lesions of the Female Lower Genital Tract.
    Acta Cytol. 2016;60:445-450.
    Abstract    

    Abstract available

  227. PLACIDI A, Capparucci P, Di Luzio A, Manca G, et al
    Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators.
    Acta Cytol. 2016;60:458-464.
    Abstract    

    Abstract available

  228. DIAZ DEL ARCO C, Sanabria Montoro MC, Garcia Lopez D, Rodriguez Escudero E, et al
    Clinical Relevance of ASC-H Cytologies: Experience in a Single Tertiary Hospital.
    Acta Cytol. 2016;60:217-24.
    Abstract    

    Abstract available

  229. SCHWOCK J, Ko HM, Dube V, Rouzbahman M, et al
    Stratified Mucin-Producing Intraepithelial Lesion of the Cervix: Subtle Features Not to Be Missed.
    Acta Cytol. 2016;60:225-31.
    Abstract    

    Abstract available

  230. BIBBO M, Wang ZX, Jones K, Solomides C, et al
    Review of Cytology Practice at Thomas Jefferson University Hospital before and after High-Risk Human Papillomavirus Testing.
    Acta Cytol. 2016;60:534-539.
    Abstract    

    Abstract available

  231. VARGAS H, Sanchez JP, Guerrero ML, Ortiz LT, et al
    Type-Specific Identification of Genital Human Papillomavirus Infection in Women with Cytological Abnormality.
    Acta Cytol. 2016;60:211-6.
    Abstract    

    Abstract available

  232. MARCOS LOPES AC, Campaner AB, Henrique LQ
    Prevalence of High-Grade Intraepithelial Neoplasia in Patients with Cytology Presenting Atypical Squamous Cells of Undetermined Significance.
    Acta Cytol. 2016;60:139-44.
    Abstract    

    Abstract available

  233. BRAR H, Hogen L, Covens A
    Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30509.
    Abstract    

    Abstract available

  234. BEAVIS AL, Gravitt PE, Rositch AF
    Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30507.
    Abstract    

    Abstract available

  235. DALTON HJ, Farley JH
    Racial disparities in cervical cancer: Worse than we thought.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30501.
    Abstract    



  236. SELVAGGI SM
    Glandular epithelial abnormalities on thinprep(R) pap tests: Clinical and cytohistologic correlation.
    Diagn Cytopathol. 2016;44:389-93.
    Abstract    

    Abstract available

  237. OMORI M, Oishi N, Nakazawa T, Nakazawa K, et al
    Extranodal NK/T-cell lymphoma, nasal type of the uterine cervix: A case report.
    Diagn Cytopathol. 2016 Feb 12. doi: 10.1002/dc.23439.
    Abstract    

    Abstract available

  238. FUJII T, Asano A, Shimada K, Tatsumi Y, et al
    Evaluation of RNA and DNA extraction from liquid-based cytology specimens.
    Diagn Cytopathol. 2016;44:833-40.
    Abstract    

    Abstract available

  239. FULMER CG, Hoda RS, Pirog EC, Park KJ, et al
    Cytomorphology of Gastric-Type Cervical Adenocarcinoma on a ThinPrep Pap Test: Report of a p16-Positive Tumor Case.
    Diagn Cytopathol. 2016;44:710-3.
    Abstract    



  240. ARIK D, Oge T, Kabukcuoglu S, Yalcin OT, et al
    Amelanotic malignant melanoma of the uterine cervix diagnosed by cervical smear.
    Diagn Cytopathol. 2016 Mar 16. doi: 10.1002/dc.23471.
    Abstract    

    Abstract available

  241. HISSONG E, Yoxtheimer LM, Pacecca A, Hoda RS, et al
    Cytology of minimal deviation endocervical adenocarcinoma (adenoma malignum) on a ThinPrep Pap test.
    Diagn Cytopathol. 2016;44:552-5.
    Abstract    



  242. TJALMA WA
    Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review.
    Eur J Obstet Gynecol Reprod Biol. 2017;210:275-280.
    Abstract    

    Abstract available

  243. TJALMA WA, Kim E, Vandeweyer K
    The impact on women's health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium.
    Eur J Obstet Gynecol Reprod Biol. 2017 Jan 5. pii: S0301-2115(17)30010.
    Abstract    

    Abstract available

  244. FRUMOVITZ M
    Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take?
    Gynecol Oncol. 2017;144:3-4.
    Abstract    



  245. BEDELL S, Manders D, Kehoe S, Lea J, et al
    The opinions and practices of providers toward the sexual issues of cervical cancer patients undergoing treatment.
    Gynecol Oncol. 2017 Jan 9. pii: S0090-8258(16)31686.
    Abstract    

    Abstract available

  246. ALEXANDRE E, Sebastien G, Renaud M, Enrica B, et al
    Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.
    Gynecol Oncol. 2017 Jan 14. pii: S0090-8258(16)31690.
    Abstract    

    Abstract available

  247. LEE YJ, Kim DY, Lee SW, Park JY, et al
    A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Gynecol Oncol. 2017 Jan 17. pii: S0090-8258(17)30001.
    Abstract    

    Abstract available

  248. GONG P, Wang Y, Gao Y, Gao M, et al
    Msi1 Promotes Tumor Progression by Epithelial-to-Mesenchymal Transition in Cervical Cancer.
    Hum Pathol. 2017 Jan 11. pii: S0046-8177(17)30015.
    Abstract    

    Abstract available

  249. RODRIGUEZ AC, Avila C, Herrero R, Hildesheim A, et al
    Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30614.
    Abstract    

    Abstract available

  250. GONZALEZ-BOSQUET E, Fernandez S, Sabra S, Lailla JM, et al
    Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.
    Int J Gynaecol Obstet. 2017;136:229-231.
    Abstract    

    Abstract available

  251. VODICKA EL, Babigumira JB, Mann MR, Kosgei RJ, et al
    Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
    Int J Gynaecol Obstet. 2017;136:220-228.
    Abstract    

    Abstract available

  252. COMPARETTO C, Epifani C, Manca MC, Lachheb A, et al
    Uptake of cervical cancer screening among the migrant population of Prato Province, Italy.
    Int J Gynaecol Obstet. 2016 Nov 25. doi: 10.1002/ijgo.12067.
    Abstract    

    Abstract available

  253. SASAKI Y, Iwanari O, Arakawa I, Moriya T, et al
    Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
    Int J Gynecol Cancer. 2016 Dec 16. doi: 10.1097/IGC.0000000000000898.
    Abstract    

    Abstract available

  254. YANG K, Park W, Huh SJ, Park BK, et al
    Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000909.
    Abstract    

    Abstract available

  255. BOGANI G, Ditto A, Martinelli F, Signorelli M, et al
    Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000902.
    Abstract    

    Abstract available

  256. KIM M, Suh DH, Kim K, Lee HJ, et al
    Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:332-338.
    Abstract    

    Abstract available

  257. NEGRAO MV, Lima JM, Silva SC, Diz MD, et al
    Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?
    Int J Gynecol Cancer. 2017 Jan 19. doi: 10.1097/IGC.0000000000000914.
    Abstract    

    Abstract available

  258. HO JC, Allen PK, Bhosale PR, Rauch GM, et al
    Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016 Nov 17. pii: S0360-3016(16)33438.
    Abstract    

    Abstract available

  259. MELL LK, Sirak I, Wei L, Tarnawski R, et al
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
    Int J Radiat Oncol Biol Phys. 2017;97:536-545.
    Abstract    

    Abstract available

  260. COOK DA, Smith LW, Law J, Mei W, et al
    Aptima HPV Assay versus Hybrid Capture(R) 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
    J Clin Virol. 2016;87:23-29.
    Abstract    

    Abstract available

  261. UPPAL S, Chapman C, Spencer RJ, Jolly S, et al
    Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
    Obstet Gynecol. 2017 Jan 9. doi: 10.1097/AOG.0000000000001819.
    Abstract    

    Abstract available

  262. DING Y, Yu AQ, Wang XL, Guo XR, et al
    Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes.
    Oncol Rep. 2016;35:2643-50.
    Abstract    

    Abstract available

  263. ZHANG X, Pan C, Zhou L, Cai Z, et al
    Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.
    BMC Cancer. 2016;16:949.
    Abstract    

    Abstract available

  264. GUERRERO-FLORES H, Apresa-Garcia T, Garay-Villar O, Sanchez-Perez A, et al
    A non-invasive tool for detecting cervical cancer odor by trained scent dogs.
    BMC Cancer. 2017;17:79.
    Abstract    

    Abstract available

  265. WEINMANN S, Naleway A, Swamy G, Krishnarajah G, et al
    Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
    PLoS One. 2017;12:e0165276.
    Abstract    

    Abstract available

  266. ALFARO A, Juarez-Torres E, Medina-Martinez I, Mateos-Guerrero N, et al
    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.
    PLoS One. 2016;11:e0169315.
    Abstract    

    Abstract available

  267. ZHENG Q, Wang T, Jiang S, Han R, et al
    Production of Polyclonal Antibody to the HPV58 E7 Protein and Its Detection in Cervical Cancer.
    PLoS One. 2016;11:e0169138.
    Abstract    

    Abstract available

  268. SHARFO AW, Breedveld S, Voet PW, Heijkoop ST, et al
    Validation of Fully Automated VMAT Plan Generation for Library-Based Plan-of-the-Day Cervical Cancer Radiotherapy.
    PLoS One. 2016;11:e0169202.
    Abstract    

    Abstract available

  269. ACERA A, Manresa JM, Rodriguez D, Rodriguez A, et al
    Increasing Cervical Cancer Screening Coverage: A Randomised, Community-Based Clinical Trial.
    PLoS One. 2017;12:e0170371.
    Abstract    

    Abstract available

  270. RAIFU AO, El-Zein M, Sangwa-Lugoma G, Ramanakumar A, et al
    Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician.
    PLoS One. 2017;12:e0170631.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;